ERRICO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 2.584
NA - Nord America 2.224
EU - Europa 1.636
SA - Sud America 344
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 117
OC - Oceania 2
Totale 7.052
Nazione #
US - Stati Uniti d'America 2.122
SG - Singapore 1.129
RU - Federazione Russa 689
VN - Vietnam 482
CN - Cina 470
IT - Italia 460
BR - Brasile 282
HK - Hong Kong 229
NL - Olanda 84
DE - Germania 75
FR - Francia 70
CA - Canada 64
BD - Bangladesh 61
IE - Irlanda 59
CI - Costa d'Avorio 58
FI - Finlandia 54
JP - Giappone 45
GB - Regno Unito 44
IN - India 28
KR - Corea 25
ZA - Sudafrica 24
EC - Ecuador 20
MX - Messico 18
IQ - Iraq 17
SE - Svezia 16
AR - Argentina 14
PL - Polonia 14
ES - Italia 13
PH - Filippine 13
ID - Indonesia 12
CO - Colombia 11
TR - Turchia 11
UA - Ucraina 11
AT - Austria 10
TH - Thailandia 9
PK - Pakistan 8
JM - Giamaica 7
MT - Malta 7
CH - Svizzera 6
CL - Cile 6
KE - Kenya 6
MA - Marocco 6
TN - Tunisia 6
UZ - Uzbekistan 6
SA - Arabia Saudita 5
TW - Taiwan 5
HU - Ungheria 4
LB - Libano 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BG - Bulgaria 3
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
MY - Malesia 3
OM - Oman 3
PS - Palestinian Territory 3
PY - Paraguay 3
UY - Uruguay 3
AU - Australia 2
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
HN - Honduras 2
KW - Kuwait 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
CG - Congo 1
CY - Cipro 1
EU - Europa 1
GN - Guinea 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
SC - Seychelles 1
SD - Sudan 1
SI - Slovenia 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 6.908
Città #
Singapore 513
San Jose 337
Hong Kong 218
Moscow 197
Ashburn 172
Beijing 158
Chandler 152
Santa Clara 107
Hanoi 104
Council Bluffs 103
Ho Chi Minh City 103
Hefei 77
Amsterdam 71
Millbury 70
Naples 63
Los Angeles 61
Napoli 57
Lauterbourg 53
New York 40
The Dalles 39
Princeton 38
Tokyo 38
Dong Ket 36
Des Moines 35
Nanjing 35
São Paulo 31
Buffalo 30
Boston 27
Haiphong 27
Redondo Beach 25
Dallas 19
Chicago 18
Nuremberg 16
Da Nang 15
Lawrence 15
Ottawa 15
Seoul 15
Johannesburg 14
San Francisco 14
Toronto 14
Milan 13
Orem 13
Salerno 13
Wilmington 13
Atlanta 12
Brooklyn 12
Shenyang 12
Changsha 11
Montreal 11
Phoenix 11
Poplar 11
Rome 11
Frankfurt am Main 10
Lappeenranta 10
London 10
Munich 10
Rio de Janeiro 10
Stockholm 10
Warsaw 10
Biên Hòa 9
Denver 9
Nanchang 8
Chennai 7
Houston 7
Hải Dương 7
Melita 7
Seattle 7
Aversa 6
Baghdad 6
Caserta 6
Guayaquil 6
Helsinki 6
Manchester 6
Nairobi 6
Norwalk 6
Porto Alegre 6
Queens 6
Quito 6
Tashkent 6
Thái Nguyên 6
Bangkok 5
Bogotá 5
Can Tho 5
Curitiba 5
Dearborn 5
Dublin 5
Fisciano 5
Formia 5
Jiaxing 5
Kyiv 5
Lombard 5
Manassas 5
Mugnano Di Napoli 5
Nocera Superiore 5
Philadelphia 5
Quartu Sant'elena 5
Querétaro 5
Quezon City 5
Ribeirão Preto 5
Tianjin 5
Totale 3.624
Nome #
Tracking the evolution of epialleles during neural differentiation and brain development: D-Aspartate oxidase as a model gene 285
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 205
DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia [*Keller S., Punzo D., Cuomo M co-primi autori] 201
Selective demethylation of two CpG sites causes postnatal activation of the Dao gene and consequent removal of D-serine within the mouse cerebellum 198
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 166
DNA methylation state of BDNF gene is not altered in prefrontal cortex and striatum of schizophrenia subjects. 159
D-aspartate oxidase gene duplication induces social recognition memory deficit in mice and intellectual disabilities in humans 159
Quantitative determination of free D-Asp, L-Asp and N-methyl-D-aspartate in mouse brain tissues by chiral separation and Multiple Reaction Monitoring tandem mass spectrometry 154
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia 151
The role of D-aspartic acid and N-methyl-D-aspartic acid in the regulation of prolactin release. 144
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 139
Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine 138
Prenatal and Early Postnatal Cerebral d -Aspartate Depletion Influences l -Amino Acid Pathways, Bioenergetic processes, and Developmental Brain Metabolism 138
A physiological mechanism to regulate D-aspartic acid and NMDA levels in mammals revealed by D-aspartate oxidase deficient mice. 136
D-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801 136
Bimodal effect of D-aspartate on brain aging processes: insights from animal models. 132
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia 130
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice 130
D-aspartate: an atypical amino acid with neuromodulatory activity in mammals. 129
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 123
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 123
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy 121
New insights on the role of free d-aspartate in the mammalian brain 121
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA?induced dyskinesia 115
Increased d-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice 114
New insights on the influence of free D-aspartate metabolism in the mammalian brain during prenatal and postnatal life 111
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease 108
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum 107
A fast and sensitive method for measuring picomole levels of total free amino acids in very small amounts of biological tissues. 107
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. 106
Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and ‘Schizophrenia-Like Behaviors’ in Mice 106
Persistent increase of d-aspartate in d-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 104
Prenatal expression of d-aspartate oxidase causes early cerebral d-aspartate depletion and influences brain morphology and cognitive functions at adulthood 101
Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients 98
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 96
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 96
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy 93
Thyroid Hormones and D-Aspartic Acid, D-Aspartate Oxidase, D-Aspartate Racemase, H2O2, and ROS in Rats and Mice 92
D-aspartate modulates nociceptive-specific neuron activity and pain threshold in inflammatory and neuropathic pain condition in mice 87
New evidence on the role of d‐aspartate metabolism in regulating brain and endocrine system physiology: From preclinical observations to clinical applications 87
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. 76
Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia 76
Dysfunctional D-aspartate metabolism in BTBR mouse model of idiopathic autism 75
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy 74
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 74
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals 74
D-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 74
d-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia 72
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity 72
D-Aspartate Depletion Perturbs Steroidogenesis and Spermatogenesis in Mice 71
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 69
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 68
Decreased Rhes mRNA levels in the brain of patients with Parkinson’s disease and MPTP- treated macaques 68
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 67
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 64
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease 63
The Emerging Role of Altered D-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies 63
High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease 63
Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients 63
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons 62
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain 62
Impact of Serotonin Deficiency on Circadian Dopaminergic Rhythms 61
Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects 61
Free D-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking D-aspartate oxidase activity 60
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients 55
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration 52
Untargeted 1H NMR-based metabolomics unveils distinct circulating biochemical signatures between treatment-resistant and non-treatment-resistant schizophrenia patients: a pilot study 9
Blood levels of D-aspartate oxidase, D-amino acid oxidase, serine racemase, and pLG72 are influenced by diagnoses of schizophrenia and autism spectrum disorder 8
Ultra-performance liquid chromatography–mass spectrometry analysis of post-mortem brain tissue reveals specific amino acid profile dysregulation in Parkinson’s disease and Alzheimer’s disease patients 7
Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson’s disease patients 6
Free D-aspartate modulates the expression of proteins linked to schizophrenia and autism spectrum disorder during early postnatal life 5
D‐ and L‐Amino Acid Blood Concentrations Are Affected in Children With Duchenne Muscular Dystrophy 5
Nusinersen rescues taurine deficiency in patients with type 1 Spinal Muscular Atrophy 4
Nusinersen corrects L-arginine deficiency in the cerebrospinal fluid of patients with severe spinal muscular atrophy 4
Variations of blood D-serine and D-aspartate homeostasis track psychosis stages 4
Post-mortem brain analysis reveals altered monoaminergic system in the dorsolateral prefrontal cortex and hippocampus in chronic schizophrenia 4
1H-NMR-based metabolomics identifies disrupted betaine metabolism as distinct serum signature of pre-frailty 3
Central Neurophysiological Alterations in Dystrophic mdx Mice Correlate With Reduced Hippocampal Levels of the Endogenous NMDA Receptor Ligand D‐Aspartate 3
Deep brain stimulation rescues the homeostasis disruption of circulating D- and L-amino acids level in men with Parkinson's disease 3
Prenatal Exposure to Lipopolysaccharide or Valproate Leads to Abnormal Accumulation of the NMDA Receptor Agonist D‐Aspartate in the Adolescent Rat Brain 2
Totale 7.052
Categoria #
all - tutte 23.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 0 10 2 3 9 0 15 67 22 75 133
2022/2023420 54 46 10 13 42 38 18 39 43 71 36 10
2023/2024319 17 51 32 9 18 15 12 81 6 5 51 22
2024/20251.621 71 108 2 5 51 99 232 93 128 148 533 151
2025/20263.547 340 372 316 286 602 92 411 180 462 239 132 115
2026/2027234 103 129 2 0 0 0 0 0 0 0 0 0
Totale 7.052